{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:15:17Z","timestamp":1794003317566,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.soc.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T06:41:21Z","timestamp":1622097681000},"page":"475-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites"],"prefix":"10.1016","volume":"30","author":[{"given":"Josh","family":"Bleicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700120212","article-title":"A\u00a0malignant tumour arising from the endothelium of the peritoneum, and producing a mucoid ascitic fluid","volume":"12","author":"Miller","year":"1908","journal-title":"J\u00a0Pathol Bacteriol"},{"key":"10.1016\/j.soc.2021.02.004_bib2","unstructured":"National Comprehensive Cancer Network. Palliative Care. Vol 1; 2020."},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1245\/s10434-020-08323-x","article-title":"The Chicago Consensus on peritoneal surface malignancies: palliative care considerations","volume":"27","author":"Plana","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1245\/s10434-020-08325-9","article-title":"The Chicago Consensus on peritoneal surface malignancies: standards","volume":"27","author":"Plana","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpainsymman.2013.10.009","article-title":"The bow tie model of 21st century palliative care","volume":"47","author":"Hawley","year":"2014","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"7","key":"10.1016\/j.soc.2021.02.004_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1377\/hlthaff.2017.0177","article-title":"Challenges in understanding and respecting patients\u2019 preferences","volume":"36","author":"Barnato","year":"2017","journal-title":"Health Aff"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-153-4-201008170-00008","article-title":"Redefining the \u201cPlanning\u201d in advance care planning: preparing for end-of-life decision making","volume":"153","author":"Sudore","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soc.2021.02.004_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1049909120917899","article-title":"The impact of varying levels of advance care planning engagement on perceptions of the end-of-life experience among caregivers of deceased patients with cancer","author":"Levoy","year":"2020","journal-title":"Am J Hosp Palliat Med"},{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jgs.12105","article-title":"Advance care planning and the quality of end-of-life care in older adults","volume":"61","author":"Bischoff","year":"2013","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.suc.2020.02.009","article-title":"Peritoneal cancers and hyperthermic intraperitoneal chemotherapy","volume":"100","author":"Pletcher","year":"2020","journal-title":"Surg Clin North Am"},{"issue":"22","key":"10.1016\/j.soc.2021.02.004_bib13","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","article-title":"Frequency of symptoms of ovarian cancer in women presenting to primary care clinics","volume":"291","author":"Goff","year":"2004","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.soc.2021.02.004_bib14","series-title":"WHO\u2019s cancer pain ladder for adults","first-page":"1","author":"World Health Organization","year":"1986"},{"key":"10.1016\/j.soc.2021.02.004_bib15","series-title":"StatPearls [Internet]","first-page":"1","article-title":"WHO Analgesic Ladder","author":"Anekar","year":"2020"},{"key":"10.1016\/j.soc.2021.02.004_bib16","first-page":"711","article-title":"Multimodal approaches and tailored therapies for pain management: the trolley analgesic model","volume":"12","author":"Cuomo","year":"2019","journal-title":"J\u00a0Pain Res"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpainsymman.2013.08.022","article-title":"Recommendations for bowel obstruction with peritoneal carcinomatosis","volume":"48","author":"Laval","year":"2014","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-020-0871-6","article-title":"Nausea and vomiting: a palliative care imperative","volume":"22","author":"Wickham","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-015-0455-3","article-title":"Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer","volume":"13","author":"Peng","year":"2015","journal-title":"World J Surg Oncol"},{"issue":"35","key":"10.1016\/j.soc.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1200\/JCO.2011.40.5712","article-title":"Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Mariani","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpainsymman.2017.10.019","article-title":"Practice patterns of medications for patients with malignant bowel obstruction using a nationwide claims database and the association between treatment outcomes and concomitant use of H2-blockers\/proton pump inhibitors and corticosteroids with octreotide","volume":"55","author":"Minoura","year":"2018","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.soc.2021.02.004_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002764","article-title":"Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer (Review)","volume":"3","author":"Feuer","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.soc.2021.02.004_bib23","first-page":"1463","article-title":"Reducing gastric secretions - a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?","volume":"17","author":"Clark","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soc.2021.02.004_bib24","doi-asserted-by":"crossref","unstructured":"Ohnuma T, Ali M, Adigun R. Supportive Care in Cancer Therapy: Anorexia and Cachexia. Humana Press; September 2008.pp. 47-86. http:\/\/doi.org\/10.1007\/978-1-59745-291-5_4.","DOI":"10.1007\/978-1-59745-291-5_4"},{"key":"10.1016\/j.soc.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (Multimodal - Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","author":"Solheim","year":"2018","journal-title":"BMJ Support Palliat Care"},{"issue":"10","key":"10.1016\/j.soc.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1089\/jpm.2018.0622","article-title":"Symptom assessment in patients with advanced cancer: are the most severe symptoms the most bothersome?","volume":"22","author":"Li","year":"2019","journal-title":"J\u00a0Palliat Med"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1188\/14.CJON.S3.38-58","article-title":"Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment","volume":"18","author":"Mitchell","year":"2014","journal-title":"Clin J Oncol Nurs"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1037\/0278-6133.26.6.660","article-title":"Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue","volume":"26","author":"Jacobsen","year":"2007","journal-title":"Heal Psychol"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1534735406298143","article-title":"A\u00a0critical review of complementary therapies for cancer-related fatigue","volume":"6","author":"Sood","year":"2007","journal-title":"Integr Cancer Ther"},{"issue":"17","key":"10.1016\/j.soc.2021.02.004_bib30","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","article-title":"Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation","volume":"32","author":"Bower","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib31","first-page":"970","article-title":"Psychotropic drugs for the management of cancer-related fatigue: a systematic review and meta-analysis","volume":"25","author":"Qu","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.soc.2021.02.004_bib32","unstructured":"National Comprehensive Cancer Network. Cancer-Related Fatigue: NCCN Clinical Practice Guidelines in Oncology; 2020."},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0148607110389335","article-title":"A.S.P.E.N. clinical guidelines: nutrition screening, assessment, and intervention in adults","volume":"35","author":"Mueller","year":"2011","journal-title":"J\u00a0Parenter Enter Nutr"},{"key":"10.1016\/j.soc.2021.02.004_bib34","series-title":"SWOG study S1316 page","year":"2020"},{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00464-009-0577-1","article-title":"A\u00a0systematic review of methods to palliate malignant gastric outlet obstruction","volume":"24","author":"Ly","year":"2010","journal-title":"Surg Endosc"},{"issue":"10","key":"10.1016\/j.soc.2021.02.004_bib36","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1007\/s00464-019-06955-z","article-title":"Palliative surgical bypass is superior to palliative endoscopic stenting in patients with malignant gastric outlet obstruction: systematic review and meta-analysis","volume":"33","author":"Mintziras","year":"2019","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-020-1803-5","article-title":"Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction- A retrospective cohort study","volume":"18","author":"Bednarsch","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2021.02.004_bib38","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s11605-017-3387-0","article-title":"Laparoscopic gastrojejunostomy for patients with unresectable gastric cancer with gastric outlet obstruction","volume":"21","author":"Ojima","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"12","key":"10.1016\/j.soc.2021.02.004_bib39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1055\/a-0657-3764","article-title":"Impact of peritoneal carcinomatosis on clinical outcomes of patients receiving self-expandable metal stents for malignant colorectal obstruction","volume":"50","author":"Park","year":"2018","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/den.13260","article-title":"Factors related to difficult self-expandable metallic stent placement for malignant colonic obstruction: a post-hoc analysis of a multicenter study across Japan","volume":"31","author":"Kuwai","year":"2019","journal-title":"Dig Endosc"},{"issue":"11","key":"10.1016\/j.soc.2021.02.004_bib41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/DCR.0b013e3182a411e7","article-title":"The efficacy of self-expanding metal stents for malignant colorectal obstruction by noncolonic malignancy with peritoneal carcinomatosis","volume":"56","author":"Kim","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.soc.2021.02.004_bib42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.11.035","article-title":"Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series","volume":"108","author":"Caceres","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.soc.2021.02.004_bib43","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1007\/s00464-016-4804-2","article-title":"Long-term outcomes of palliation for unresectable colorectal cancer obstruction in patients with good performance status: endoscopic stent versus surgery","volume":"30","author":"Ahn","year":"2016","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/DCR.0000000000000061","article-title":"The role of primary colectomy after successful endoscopic stenting in patients with obstructive metastatic colorectal cancer","volume":"57","author":"Lee","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.soc.2021.02.004_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.suronc.2016.05.025","article-title":"Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: incidence, management and outcomes","volume":"25","author":"Valle","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.soc.2021.02.004_bib46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1148\/rg.294085223","article-title":"Fistulas in malignant gynecologic disease: etiology, imaging, and management","volume":"29","author":"Narayanan","year":"2009","journal-title":"RadioGraphics"},{"issue":"5","key":"10.1016\/j.soc.2021.02.004_bib47","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.amjsurg.2013.12.024","article-title":"Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis","volume":"207","author":"Rivard","year":"2014","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.25453","article-title":"Palliation of malignant ascites","volume":"120","author":"Hodge","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/082585971503100406","article-title":"Indwelling peritoneal catheters for managing malignancy-associated ascites","volume":"31","author":"Wong","year":"2015","journal-title":"J\u00a0Palliat Care"},{"issue":"5","key":"10.1016\/j.soc.2021.02.004_bib51","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00270-017-1872-1","article-title":"Safety and effectiveness of palliative tunneled peritoneal drainage catheters in the management of refractory malignant and non-malignant ascites","volume":"41","author":"Knight","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.soc.2021.02.004_bib52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/jpm.2012.0535","article-title":"Outcomes of permanent peritoneal ports for the management of recurrent malignant ascites","volume":"16","author":"Coupe","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.soc.2021.02.004_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/CMAR.S100210","article-title":"Drainage of malignant ascites: patient selection and perspectives","volume":"9","author":"Stukan","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.soc.2021.02.004_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijsu.2015.09.074","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery","volume":"23","author":"Valle","year":"2015","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jso.21321","article-title":"Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients","volume":"100","author":"Valle","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2021.02.004_bib56","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/IGC.0000000000000809","article-title":"Hyperthermic intraperitoneal perfusion chemotherapy and cytoreductive surgery for controlling malignant ascites from ovarian cancer","volume":"26","author":"Ba","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.soc.2021.02.004_bib57","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00464-013-2800-3","article-title":"Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites","volume":"27","author":"Ba","year":"2013","journal-title":"Surg Endosc"},{"issue":"10","key":"10.1016\/j.soc.2021.02.004_bib58","first-page":"4293","article-title":"The role of \u201cclosed abdomen\u201d hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience","volume":"24","author":"Orgiano","year":"2016","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejso.2007.05.015","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer","volume":"34","author":"Facchiano","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2021.02.004_bib60","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib61","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3892\/or.2012.1913","article-title":"B\u00a0ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites","volume":"28","author":"Cui","year":"2012","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.soc.2021.02.004_bib62","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-013-3224-y","article-title":"Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites","volume":"21","author":"Randle","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-020-01956-y","article-title":"Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites","volume":"18","author":"Jiao","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2021.02.004_bib64","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/jpm.2013.0397","article-title":"Palliative gastrostomy in the setting of voluminous ascites","volume":"17","author":"O\u2019connor","year":"2014","journal-title":"J\u00a0Palliat Med"},{"issue":"2","key":"10.1016\/j.soc.2021.02.004_bib65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1245\/s10434-012-2643-5","article-title":"Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites","volume":"20","author":"Shaw","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2021.02.004_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/TA.0000000000000764","article-title":"Outcomes after emergency abdominal surgery in patients with advanced cancer","volume":"79","author":"Cauley","year":"2015","journal-title":"J\u00a0Trauma Acute Care Surg"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib67","article-title":"Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer (Cochrane Review)","volume":"4","author":"Cousins","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.soc.2021.02.004_bib68","doi-asserted-by":"crossref","first-page":"343","DOI":"10.21614\/chirurgia.114.3.343","article-title":"Surgical management of malignant intestinal obstruction: outcome and prognostic factors","volume":"114","author":"Bento de","year":"2019","journal-title":"Chirurgia (Bucur)"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamasurg.2013.4059","article-title":"Palliative surgery for malignant bowel obstruction from carcinomatosis a systematic review","volume":"149","author":"Olson","year":"2014","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.soc.2021.02.004_bib70","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10434-001-0632-1","article-title":"Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer","volume":"8","author":"Blair","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2021.02.004_bib71","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/jpm.2013.0324","article-title":"Use of corticosteroids for anorexia in palliative medicine: a systematic review","volume":"17","author":"Miller","year":"2014","journal-title":"J\u00a0Palliat Med"},{"issue":"1","key":"10.1016\/j.soc.2021.02.004_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.21037\/apm.2018.11.01","article-title":"Prokinetics and ghrelin for the management of cancer cachexia syndrome","volume":"8","author":"Malik","year":"2019","journal-title":"Ann Palliat Med"},{"issue":"7","key":"10.1016\/j.soc.2021.02.004_bib74","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"2017","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.soc.2021.02.004_bib75","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320721000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320721000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:04:06Z","timestamp":1760961846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320721000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1055320721000156"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2021.02.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Palliative Approach to Management of Peritoneal Carcinomatosis and Malignant Ascites","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}